Universitatsklinikum Heidelberg
Records under this name other than the patents Universitatsklinikum Heidelberg holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 2 patents it holds.
Showing 1 to 10 of 10 · Back to Universitatsklinikum Heidelberg
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,123,368 | Immunosuppressive blood cells and methods of producing the same Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,968,750 | Malaria Vaccines Based on Apicomplexan Ferlins, Ferlin-Like Proteins and Other C2-DOMAIN Containing Proteins Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 11,419,832 | Bis-Choline Tetrathiomolybdate for Treating Wilson Disease Formerly held In force · High confidence | In force | High confidence | |
| US 11,510,944 | Bis-Choline Tetrathiomolybdate for Treating Wilson Disease Formerly held In force · High confidence | In force | High confidence | |
| US 12,233,088 | Bis-Choline Tetrathiomolybdate for Treating Wilson Disease Formerly held In force · Low confidence | In force | Low confidence | |
| US 9,850,308 | Neutralization of CD95 activity blocks invasion of glioblastoma cells in vivo Lapsed on the fee record Ended Dec 26, 2025 · From the USPTO record | Lapsed on the fee record | Ended Dec 26, 2025 | From the USPTO record |
| US 9,664,684 | Methods of Treating Cancer Using Chemovirotherapy Lapsed on the fee record Ended May 30, 2025 · High confidence | Lapsed on the fee record | Ended May 30, 2025 | High confidence |
| US 9,428,564 | Muscle function enhancing peptide Lapsed on the fee record Ended Aug 30, 2024 · From the USPTO record | Lapsed on the fee record | Ended Aug 30, 2024 | From the USPTO record |
| US 9,309,320 | Neutralization of CD95 activity blocks invasion of glioblastoma cells in vivo Lapsed on the fee record Ended Apr 12, 2024 · From the USPTO record | Lapsed on the fee record | Ended Apr 12, 2024 | From the USPTO record |
| US 10,155,041 | Bacterial phospholipase inhibitors as modulator of colonic bacterial flora Lapsed on the fee record Ended Dec 18, 2022 · From the USPTO record | Lapsed on the fee record | Ended Dec 18, 2022 | From the USPTO record |